ask="N/A"
ask_size="N/A"
average_daily_volume="365802"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="+0.47"
change_from_200_day_moving_average="-1.80"
change_from_50_day_moving_average="1.09"
change_from_52_week_high="-12.77"
change_From_52_week_low="17.86"
change_in_percent="+0.98%"
close="48.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23936000"
high="48.36"
high_52_weeks="60.98"
last_trade_date="2/16/2017"
last_trade_price="48.21"
last_trade_size="27754"
last_trade_time="4:00pm"
low="46.83"
low_52_weeks="30.35"
market_capitalization="1.31B"
moving_average_200_day="50.01"
moving_average_50_day="47.12"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="47.81"
pe_ratio="5.39"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-3.60%"
percent_change_from_50_day_moving_average="+2.32%"
percent_change_from_52_week_high="-20.94%"
percent_change_from_52_week_low="+58.85%"
previous_close="47.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.21"
price_per_sales="3.36"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="227570"
weeks_range_52="30.35 - 60.98"
